Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021)
Insight Molecular Diagnostics (IMDX) posted Equity Income of -$270000.0 for Q1 2021, up 37.93% sequentially from -$435000.0 in Q4 2020, and up 17.93% YoY from -$228943.3 in Q1 2020.
Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 2 years of Equity Income data on file, last reported at -$270000.0 in Q1 2021.
- Quarterly Equity Income rose 17.93% year-over-year to -$270000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was -$270000.0 (up 82.55% YoY) and the FY2021 annual result came in at -$270000.0, up 82.55% from the prior year.
- Equity Income improved to -$270000.0 in Q1 2021 per IMDX's latest filing, from -$435000.0 in the prior quarter.
- The five-year high for Equity Income was -$270000.0 in Q1 2021, with the low at -$482000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 6.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -270,000.00 |
| Dec 31, 2020 | -435,000.00 |
| Sep 30, 2020 | -482,000.00 |
| Jun 30, 2020 | -301,000.00 |
| Mar 31, 2020 | -329,000.00 |